Death toll mounts as FDA denies HCQ for outpatient therapy
Source: WND.com. Author: Elizabeth Lee Vliet, M.D. On Aug. 10 the FDA denied the urgent request for emergency approval for COVID-19 outpatient preventive and early treatment use of hydroxychloroquine (HCQ)